10 results
Biologic Events Leading to Chronic GVHD #Pathophys #Honc #Pharm #GVHD #GraftVersusHostDisease #Therapeutic #Pathways #NEJM
GVHD #Pathophys #Honc ... #Pharm #GVHD #GraftVersusHostDisease ... Therapeutic #Pathways #NEJM
Signaling Mechanism of PD-1 and PD-L1 and Inhibition of PD-1 Signaling in Microsatellite-Instability–High Cancers. MHC1 denotes
Pathophysiology #Honc ... #Pharm #PD1 #PDL1 ... MicrosatelliteInstability #NEJM
Pembrolizumab Response Rate by Tumor Type #EBM #Honc #Pharm #Pembrolizumab #Response #TumorType #Colorectal #Endometrial #Biliary #NEJM
Tumor Type #EBM #Honc ... #Pharm #Pembrolizumab ... Endometrial #Biliary #NEJM
Immune Checkpoint–Blocking Antibodies Approved by the Food and Drug Administration #Pharm #Honc #Checkpoint #Blockade #FDA #Antibodies
Administration #Pharm ... #Honc #Checkpoint ... #Indications #NEJM
Gastric Cancer in Chest Radiograph - A plain radiograph of the chest showed a round, irregular
endoscopy revealed a diffusely ... Clinical #Radiology #GI ... #Honc #CXR #EGD ... GastricCancer #NEJM
Upper endoscopy revealed a pigmented mass in the duodenal bulb (Panel A) and two additional masses
B) #Clinical #GI ... #Derm #Honc #Melanoma ... EGD #Metastatic #NEJM
Diffuse Melanosis Cutis - Several weeks earlier, a progressive gray–blue discoloration of the skin had developed.
Diffuse Melanosis ... Clinical #Derm #Honc ... Hyperpigmentation #NEJM
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
Pathophysiology #IM #Honc ... #Pharm #GVHD #GraftVersusHostDisease ... Immunosuppression #NEJM
Diagnostic Algorithm for Non–Small-Cell Lung Cancer (NSCLC). The upper portion of the algorithm shows the morphologic
Diagnostic Algorithm ... portion of the algorithm ... #Diagnosis #Honc ... #Algorithm #NSCLC ... #PDL1 #NEJM
IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis
Algorithm for the management of acute bacterial rhinosinusitis.
Rhinosinusitis Algorithm ... 18 - Overall Harm ... NNH = 8 (mostly GI ... #Antibiotics #Algorithm